Clinical trial

Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)

NCT00990184

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-09-01

PhasePHASE3

Study timeline

Study start (unknown)2009-09-01Date precision: month

Registry last updated2012-11-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Impaired Fasting Glucoseunresolved

Prediabetesunresolved

Interventions

ColesevelamDRUG · verified · RxNorm: colesevelam

placeboOTHER

Sponsors & collaborators

Seattle Institute for Biomedical and Clinical Researchlead sponsor

VA Puget Sound Health Care Systemcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00990184 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.